Title: Bacterial Co-Infections in COVID-19 Positive Patients in a Tertiary Care Hospital in Southern Assam

Authors: Dr Subhrendu Sekhar Sen, Dr Anindita Kurmi

 DOI: https://dx.doi.org/10.18535/jmscr/v10i5.08

Abstract

Owing to the limited therapeutic options, the current ongoing pandemic COVID-19 pandemic has raised concerns over secondary infections .Country and region-specific clinical data encompassing various infections are needed in guiding evidence-based treatment of COVID-19. To fill this major gap in our knowledge, we conducted a prospective study to ascertain the actual burden & molecular profile of pathogens causing s bacterial co infections in COVID-19 patients.

Out of 100 patients, 38 were admitted to ICU and 62 in wards. The outcome measure analysis was done in 24 patients whose clinical samples were culture positive. Blood was the predominant sample followed by urine. In blood, Klebsiella pneumoniae was the commonest isolate and was resistant to most antibiotics except colistin. Candida species was the predominant pathogen in urine.

References

  1. Gupta R.K. Bacterial pneumonia and pandemic influenza planning. Emerg. Infect. Dis. 2008;14:1187–1192. [PMC free article] [PubMed] [Google Scholar]
  2. Louise Lansbury, Benjamin Lim, Vadsala Baskaran, Shen Lim Wei. Co-infections in people with COVID-19: a systematic review and meta-analysis. J Infect. 2020;81(2):266–275. doi: 10.1016/j.jinf.2020.05.046. [PMC free article] [PubMed] [CrossRef] [Google Scholar]
  3. Kolenda C. Assessment of respiratory bacterial coinfections among severe acute respiratory syndrome coronavirus 2-positive patients hospitalized in intensive care units using conventional culture and Bio Fire, Film Array Pneumonia Panel Plus Assay. Open Forum Infect. Dis. 2020;7 [PMC free article] [PubMed] [Google Scholar]
  4. Soriano M.C. Low incidence of co-infection, but high incidence of ICU-acquired infections in critically ill patients with COVID-19. J. Infect. 2021;82:e20–e21. [PMC free article] [PubMed] [Google Scholar]
  5. Stevenson D.R. Improving antimicrobial stewardship in critically-ill patients with COVID-19. Clin. Infect. Dis. 2020 doi: 10.1093/cid/ciaa1559. Published online October 11, 2020. [PMC free article] [PubMed] [CrossRef] [Google Scholar]
  6. Contou D. Bacterial and viral co-infections in patients with severe SARS-CoV-2 pneumonia admitted to a French ICU. Ann. Intensive Care. 2020;10:119. [PMC free article] [PubMed] [Google Scholar]
  7. Dudoignon E. Bacterial pneumonia in COVID-19 critically ill patients: a case series. Clin. Infect. Dis. 2021;72:905–906. [PMC free article] [PubMed] [Google Scholar]
  8. Vaughn V.M. Empiric antibacterial therapy and community-onset bacterial co-infection in patients hospitalized with COVID-19: A multi-hospital cohort study. Clin. Infect. Dis. 2020 doi: 10.1093/cid/ciaa1239. Published online August 21, 2020. [PMC free article] [PubMed] [CrossRef] [Google Scholar
  9. Saeed NK, Al-Khawaja S, Alsalman J, Almusawi S, Albalooshi NA, Al-Biltagi M. Bacterial co-infection in patients with SARS-CoV-2 in the Kingdom of Bahrain. World J Virol. 2021 Jul 25;10(4):168-181. doi: 10.5501/wjv.v10.i4.168. PMID: 34367932; PMCID: PMC8316874.

Corresponding Author

Dr Anindita Kurmi

PGT, Department of Microbiology, SMCH